This is the authors' abstract. We don't add key points for this paper.
The interrelationships of serologic and clinical features and the HLA–DR, MB, and MT specificities were examined in 70 white patients with systemic lupus erythematosus. HLA–DR2 and MB1 were significantly increased when compared with controls from the Eighth International Histocompatibility Testing Workshop but not with local controls. DR2 and DR3 correlated with increased seroreactivity (anti‐Ro, antiDNA, rheumatoid factor, and hyperglobulinemia), and anti‐Ro with clinically overt sicca complex. Thus, DR2 and DR3 may be markers of a major histocompatibility complex–mediated immune hyperresponsiveness that affects expression of systemic lupus erythematosus.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ahearn et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: